Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 10, 2015 12:16:04 GMT -5
MannKind is under attach by Wall Street in particular Jason Karp. He and his allies will be relentless to rattle the confidence of shareholders, force you to sell and make $ while you suffer a loss. Keep in mind, MannKind has Alfred Mann, he has spent a considerable amount of time and $ to achieve FDA approval; he is not going to let MannKind slip into any financially difficulty during this transition period. If one looks at put option pricing, there is a fair probability it will fall below $2.00.
My recommendation is to think like a business owner, you own a piece a wonderful company. Would you sell your property because someone told you it was worth far less than the price you paid? I don't know where the share price will be a year or two from now, however, I am extremely confident sales of Afrezza will be much greater than where they are now. I am a scientist and engineer, in fact nearly the same degrees as Al Mann and I can differentiate science from science fiction; MannKind is the real deal.
|
|
|
|
Post by kball on Sept 10, 2015 12:35:40 GMT -5
*Gulp*
|
|
|
|
Post by mssciguy on Sept 10, 2015 12:37:41 GMT -5
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 10, 2015 12:56:50 GMT -5
Do not misinterpret my thread, it is only to prepare people for the possibility of sub $2 share price. I base this solely on past experience of hedge funds crushing stock prices and option pricing. The fact Jason Karp is heavily short and one can sell the January 2017 $2 puts for approximately $0.70 lead me to create this thread. MannKind is my second largest position and I have no intentions of selling for a very long time.
|
|
|
|
Post by harrys on Sept 10, 2015 13:07:16 GMT -5
Are you not worried about the potential MNKD is forced into bankruptcy as they cannot continue operation or pay their debt at those prices? I guess the silverlining is as longs we can only lose 100% of our investment....
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 10, 2015 13:07:53 GMT -5
You are not wrong, however, Wall Street is trying to make you believe you are wrong. My advice to you is to not look at day to day price swings. One day you will be very happy with both the products MannKind manufactures and the share price. Hang tight! |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 10, 2015 13:09:58 GMT -5
Are you not worried about the potential MNKD is forced into bankruptcy as they cannot continue operation or pay their debt at those prices? I guess the silverlining is as longs we can only lose 100% of our investment.... The last thing I am worried about is MannKind going into bankruptcy. This is exactly what Wall Street wants you to believe. Not going to happen! |
|
|
|
Post by harrys on Sept 10, 2015 13:14:59 GMT -5
I'd really like to believe Al is prepared to swoop in at the 11th hour but three things have made me less confident that is a possibility a) Al's striking silence b) stepping down within the company c) Al's age and possible health. And the wild card possibility d) maybe he's just as disgusted as we are with Wall Street and doesn't see an avenue to overcome the current predicament.
|
|
|
|
Post by patryn on Sept 10, 2015 13:29:59 GMT -5
Not only would I be mentally prepared, I think I would need to be fiscally prepared to back up the truck and double down on my investment should it fall below $2. Going through the scenarios, at the current cash burn rate, MNKD is in no danger of bankruptcy in the next two years and even in liquidation, I get a minimum price of $2 for just the tax write offs and the patent portfolio.
|
|
|
|
Post by kc on Sept 10, 2015 13:51:37 GMT -5
Dumb me! I still believe that before a MannKind bankruptcy would occur that Sanofi would do the benevolent thing and either Buy into the company or buy it out. They do not want to have a bankrupt partner supplying them Afrezza. There is a lot of unknowns with MannKind. It seems that we are in a cone of silence and can't hear anything good, bad or meaningful from Sanofi or the company. This leads me to believe that its business as usual for both of them as they develop / implement their Afrezza sales & marketing plan.
Does anybody on this board really believe that Sanofi would let MannKind fail or go bankrupt?
I think there are a lot of smart big Pharma players & activist investors that would scoop up MannKind in minute. Today's price is a 75% off sale of the overall value unless Afrezza leaves the market place. To much potential for a blockbuster in the USA and Globally once we really get moving. You can't judge 7 months of sales to determine if we have a winner or loser. |
|
|
|
Post by harrys on Sept 10, 2015 13:56:08 GMT -5
If MNKD went Bankrupt would Sanofi not come in and buy up the rights to Afrezza for pennies on the dollar and continue commercialization? I'd like to understand your notion that Sanofi would not allow MNKD to go bankrupt. Could you clarify?
|
|
|
|
Post by kc on Sept 10, 2015 14:00:23 GMT -5
If MNKD went Bankrupt would Sanofi not come in and buy up the rights to Afrezza for pennies on the dollar and continue commercialization? I'd like to understand your notion that Sanofi would not allow MNKD to go bankrupt. Could you clarify? They just would not allow a partner to go bankrupt. It would not look good for future partnerships with the company. Al Mann will not let it go bankrupt either. They would do a tender offer and take it private. I am surprised that has not occurred yet. He has enough shares along with institutional investors to make that happen for a very cheap price. |
|
|
|
Post by dreamboatcruise on Sept 10, 2015 14:11:02 GMT -5
Hmmm... Scotch or Gin... which would best mentally prepare me? Maybe I'll take a wait and see approach rather than being proactive.
Two weeks from now I'll be a buyer if we dip back to recent lows or below... but of course it will probably do it while I have a liquidity problem being in escrow.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Sept 10, 2015 14:12:36 GMT -5
If a shareholder is uncertain, I recommend listening to a few conference calls where Afrezza potential and company finances are discussed. I am extremely impressed with Matt Pfeiffer's technical and financial knowledge, he brings it down to a level non-technical people can understand. I have emailed Matt regarding a couple of events and he graciously replied back with answers that satisfied my questions.
So be patient, good things come to those that can wait.
|
|
|
|
Post by mssciguy on Sept 10, 2015 14:21:38 GMT -5
If a shareholder is uncertain, I recommend listening to a few conference calls where Afrezza potential and company finances are discussed. I am extremely impressed with Matt Pfeiffer's technical and financial knowledge, he brings it down to a level non-technical people can understand. I have emailed Matt on a couple of events and he graciously replied back with answers that satisfied my questions. So be patient, good things come to those that can wait. Check this out www.nasdaq.com/symbol/mnkd/institutional-holdingsThere is accumulation in progress. Also, the number of institutional shares correlates roughly with the number of shares short. Coincidence, maybe, maybe not. |
|
